Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 PARMAX PHARMA LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2018 ,inter alia, to consider and approve Pursuant to Regulations 29(1)(a) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to notify that a meeting of the Board of Directors of the Company is proposed to be held on Sunday, the 11th November, 2018 at registered...
03-11-2018
Bigul

Sub.: Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2018.

 Dear Sir/Madam, Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the certificate received from Mr. Samsad Alam Khan, Practicing Company Secretary, for the half-year ended 30th September, 2018 confirming the compliance of Regulation 40(9) of SEBI (Listing Obligations and Disclosure...
23-10-2018
Bigul

Shareholding for the Period Ended September 30, 2018

 Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here
18-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 Dear Sir / Madam, Sub.: Intimation of change in Compliance officer and KMP This to inform you that the board of directors of the company at its meeting held today i.e. 9th October, 2018, inter alia transacted the following Business: 1. Board of Directors has accepted the resignation of Ms. Isha Shrotriya from the post of Company Secretary and Compliance Officer of the Company with effect from 7th October, 2018.
09-10-2018
Bigul

ANNOUNCEMENT UNDER REGULATION 30 (LODR)-UPDATES (APPOINTMENT OF COMPANY SECRETARY)

 Dear Sir / Madam, Sub.: Intimation of change in Compliance officer and KMP This to inform you that the board of directors of the company at its meeting held today i.e. 9th October, 2018, inter alia transacted the following Business: 1. The Board has approved the appointment of Mr. Yash Vora as Company Secretary Cum Compliance Officer of the company with effect from 8th October, 2018.
09-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018 (Revised)

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr. Alkesh R. GosaliaDesignation :- Director
09-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr. Alkesh R. GosaliaDesignation :- Director
09-10-2018
Bigul

Compliance Certificate Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 For Half Year Ended On 30Th September, 2018.

 Dear Sir/Madam, Pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained by the company's Registrar and Share Transfer Agent, viz., Purva Shareregistry (India) Private Limited which is SEBI approved Permanent Category-I Registrar and Transfer...
04-10-2018
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Parmax Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
25-09-2018
Bigul

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Dear Sirs, This is to inform you that the 24th Annual General Meeting of the company held on Saturday, 22nd September, 2018 at 3:00 PM at the registered office of the company situated at Plot No. 20, Survey No. 52, Rajkot- Gondal National Highway No. 27, Hadamtala, Tal. Kotda Sangani, Dist. Rajkot, Gujarat-360311. In this regard, please find enclosed the following:...
25-09-2018
Next Page
Close

Let's Open Free Demat Account